Pre-market Hot Trades in US Stocks

Upexi pre-market up 7.24%. Based on recent important news:

1. On July 22, Upexi submitted a preliminary prospectus for a potential resale of up to 48.03 million shares of common stock. This news may trigger positive market expectations for the company's stock price, leading to an increase.

2. On July 21, Upexi announced the purchase of 100,000 SOL for $17.7 million, bringing its total holdings to 1.82 million, with an unrealized gain of $58 million. This investment increased the company's asset value and boosted market confidence.

3. On July 21, Upexi estimated that its SOL holdings could generate approximately $26 million in staking income annually. This expected increase in income may further drive up the stock price.

DeFi Development, pre-market up 7.14%. Based on recent key news:

1. On July 21, DeFi Development Corp increased its SOL holdings to 999,999, demonstrating the company's strong confidence in cryptocurrency, which drove the stock price up.

2. On July 22, the company raised $19 million through equity financing and purchased 141,383 SOL, further enhancing market confidence.

3. On July 14, the company set a target of achieving 0.1650 SPS by June 2026, expecting a growth of 261%, which sparked investor optimism.

Top Gainers in Pre-market US Stocks

INVO Fertility pre-market up 83.92%. Based on recent key news:

1. On July 21, the U.S. Securities and Exchange Commission released an important document that could significantly impact INVO Fertility, leading to a substantial increase in stock price.

2. On July 20, the company announced a new fertility treatment technology, and the market reacted positively, driving the stock price up.

3. On July 19, industry analysts upgraded their rating for INVO Fertility, further enhancing market confidence.

Bloomz pre-market up 61.12%. Based on recent key news:

1. On July 21, Bloomz issued an important announcement through ACCESS Newswire, resulting in a significant stock price increase of 61.12%.

2. On July 20, industry analysts raised their earnings expectations for Bloomz, further driving up the stock price.

3. On July 19, favorable macroeconomic data boosted market confidence, indirectly pushing up Bloomz's stock price.

Medpace Holdings, pre-market up 45.66%. Based on recent important news:

1. On July 22, Medpace released its second-quarter financial report, with revenue of $603.3 million, exceeding the expected $538.8 million, and a net profit of $3.10 per share, up from $2.75 in the same period last year, driving the stock price up by 45%

2. On July 22, the company raised its revenue forecast for 2025 to between $2.42 billion and $2.52 billion, exceeding analysts' expectations of $2.19 billion, further boosting market confidence.

3. On July 22, Medpace raised its full-year earnings per share forecast to between $13.76 and $14.53, surpassing market expectations of $12.69, enhancing investor confidence